Dr Reddys Laboratories Ltd Exclusive marketing agreement

Dr Reddys Laboratories Ltd to market the drug Qdenga has entered in marketting ageement with Takeda Biopharmaceuticals India Private Limited This is an exclusive distribution and marketing agreement for Qdenga in the private market in India Pursuant to terms of the Agreement, Dr. Reddy’s will be exclusively responsible for distribution and marketing of Qdenga in the private market in India, while Takeda will retain commercialization rights in the public market in India, and will be responsible for manufacturing and importation of the vaccine. The partnership is aligned with Dr. Reddy's strategy to strengthen its vaccines business in India and supports broader public health efforts aimed at addressing the significant burden of dengue in India. My Opinion : This is a postive news for Drready and the stock may show uptrend from here for a while subject to overall Index Trend. Disclaimer : I am not holding this stock and this is not an recommendaion to enter at current price